Skip to content
Back to Guavy Wire
Stocks

P&G Buys Thorne in Record-Breaking Wellness Deal

Instruments
PG
Share

Procter & Gamble (P&G) has made a significant move in the health and wellness market by acquiring Thorne, a leading premium supplements brand. The $3.8 billion all-cash deal underscores P&G's strategy to accelerate growth in higher-margin wellness categories.

The acquisition expands P&G's portfolio of wellness brands, which already includes New Chapter, Metamucil, and Align Probiotic. Thorne was taken private by L Catterton in a $680 million transaction in 2023 and is expected to generate approximately $650 million in sales this year.

The deal delivers a substantial return for L Catterton amid heightened consolidation in the vitamins, minerals, and supplements (VMS) market. Major consumer goods companies are increasing investments to expand their health-focused product offerings.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc